Related references
Note: Only part of the references are listed.Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
Samagya Banskota et al.
CELL (2022)
Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing
Andrew Anzalone et al.
NATURE BIOTECHNOLOGY (2022)
CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer
Baozhu Yi et al.
ONCOGENE (2022)
Dual-AAV delivering split prime editor system for in vivo genome editing
Shengyao Zhi et al.
MOLECULAR THERAPY (2022)
Multiplexed genome regulation in vivo with hyper-efficient Cas12a
Lucie Y. Guo et al.
NATURE CELL BIOLOGY (2022)
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro
Leiping Zeng et al.
NATURE COMMUNICATIONS (2022)
Therapeutic in vivo delivery of gene editing agents
Aditya Raguram et al.
CELL (2022)
Optimization of AsCas12a for combinatorial genetic screens in human cells
Peter C. DeWeirdt et al.
NATURE BIOTECHNOLOGY (2021)
Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing
Rongming Liu et al.
TRENDS IN BIOTECHNOLOGY (2021)
In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice
Luke W. Koblan et al.
NATURE (2021)
Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice
Di Yin et al.
NATURE BIOTECHNOLOGY (2021)
CRISPR technologies for precise epigenome editing
Muneaki Nakamura et al.
NATURE CELL BIOLOGY (2021)
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
H. Frangoul et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice
Sikai Ling et al.
NATURE BIOMEDICAL ENGINEERING (2021)
CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice
Ralf S. Schmid et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
A CRISPR-Cas9 repressor for epigenetic silencing of KRAS
Jingwen Liu et al.
PHARMACOLOGICAL RESEARCH (2021)
LEBER CONGENITAL AMAUROSIS DUE TO CEP290 MUTATIONS-SEVERE VISION IMPAIRMENT WITH A HIGH UNMET MEDICAL NEED A Review
Bart P. Leroy et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)
Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice
Ana M. Moreno et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD
Charis L. Himeda et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth in vitro and in vivo
Chunjing Li et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
James K. Nunez et al.
CELL (2021)
Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice
Pengpeng Liu et al.
NATURE COMMUNICATIONS (2021)
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
F. Chemello et al.
SCIENCE ADVANCES (2021)
CRISPR activation of long non-coding RNA DANCR promotes bone regeneration
Nuong Thi Kieu Nguyen et al.
BIOMATERIALS (2021)
Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing
Xiaoshu Xu et al.
MOLECULAR CELL (2021)
Base editing of haematopoietic stem cells rescues sickle cell disease in mice
Gregory A. Newby et al.
NATURE (2021)
Transgenic mice for in vivo epigenome editing with CRISPR-based systems
Matthew Gemberling et al.
NATURE METHODS (2021)
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Julian D. Gillmore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
Jennifer R. Hamilton et al.
CELL REPORTS (2021)
Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications
Tian Tang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases
Colin T. Konishi et al.
JOURNAL OF BIOMEDICAL RESEARCH (2021)
Base and Prime Editing Technologies for Blood Disorders
Panagiotis Antoniou et al.
FRONTIERS IN GENOME EDITING (2021)
Multiple Input Sensing and Signal Integration Using a Split Cas12a System
Hannah R. Kempton et al.
MOLECULAR CELL (2020)
Treatment of a Mouse Model of ALS by In Vivo Base Editing
Colin K. W. Lim et al.
MOLECULAR THERAPY (2020)
Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants
Kira S. Makarova et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
Stanley Zhou et al.
NATURE COMMUNICATIONS (2020)
Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering
Zheng Yanli et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Gene editing and CRISPR in the clinic: current and future perspectives
Matthew P. Hirakawa et al.
BIOSCIENCE REPORTS (2020)
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott et al.
CELL (2020)
CRISPR/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off-Target Evaluation, and Strategies to Mitigate Off-Target Effects
Hakim Manghwar et al.
ADVANCED SCIENCE (2020)
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
Kurt Selle et al.
MBIO (2020)
CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice
Jin Li et al.
MOLECULAR THERAPY (2020)
Directed evolution of adenine base editors with increased activity and therapeutic application
Nicole M. Gaudelli et al.
NATURE BIOTECHNOLOGY (2020)
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Michelle F. Richter et al.
NATURE BIOTECHNOLOGY (2020)
Dual base editor catalyzes both cytosine and adenine base conversions in human cells
Xiaohui Zhang et al.
NATURE BIOTECHNOLOGY (2020)
A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing
Julian Grunewald et al.
NATURE BIOTECHNOLOGY (2020)
Recent Advances in CRISPR/Cas9 Delivery Strategies
Bon Ham Yip
BIOMOLECULES (2020)
Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA
Zongliang Gao et al.
NUCLEIC ACIDS RESEARCH (2020)
Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
Tuo Wei et al.
ACS NANO (2020)
Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome-Associated Cardiomyopathy
Ulrich Hanses et al.
CIRCULATION (2020)
Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning
Mandana Arbab et al.
CELL (2020)
Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
Muhammad Naeem et al.
CELLS (2020)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone et al.
NATURE BIOTECHNOLOGY (2020)
Cas9 gene therapy for Angelman syndrome trapsUbe3a-ATSlong non-coding RNA
Justin M. Wolter et al.
NATURE (2020)
Base editing: advances and therapeutic opportunities
Elizabeth M. Porto et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
M. Martinez-Lage et al.
NATURE COMMUNICATIONS (2020)
CRISPR based editing of SIV proviral DNA in ART treated non-human primates
Pietro Mancuso et al.
NATURE COMMUNICATIONS (2020)
Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells
Kasturi Sengupta et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
CRISPR-CasΦ from huge phages is a hypercompact genome editor
Patrick Pausch et al.
SCIENCE (2020)
Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases
Shao-Shuai Wu et al.
THERANOSTICS (2020)
CasX enzymes comprise a distinct family of RNA-guided genome editors
Jun-Jie Liu et al.
NATURE (2019)
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
Colette Moses et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis
Naresh Poondla et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Targeted demethylation of the SARI promotor impairs colon tumour growth
Qin Wang et al.
CANCER LETTERS (2019)
Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-Cas
Adam E. Dolan et al.
MOLECULAR CELL (2019)
miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study
Bethany N. Hannafon et al.
BMC CANCER (2019)
A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene
Dwi U. Kemaladewi et al.
NATURE (2019)
Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration
Sanne E. Klompe et al.
NATURE (2019)
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease
David Adams et al.
NATURE REVIEWS NEUROLOGY (2019)
RNA-guided DNA insertion with CRISPR-associated transposases
Jonathan Strecker et al.
SCIENCE (2019)
Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application
Sikandar Hayat Khan
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Multiplexed genome engineering by Cas12a and CRISPR arrays encoded on single transcripts
Carlo C. Campa et al.
NATURE METHODS (2019)
The Role of Non-coding RNAs in Oncology
Frank J. Slack et al.
CELL (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection
Leah H. Cobb et al.
PLOS ONE (2019)
Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases
Odatha W. Kotagama et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS
Wei Zhuo et al.
GASTROENTEROLOGY (2019)
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
Morgan L. Maeder et al.
NATURE MEDICINE (2019)
Functionally diverse type V CRISPR-Cas systems
Winston X. Yan et al.
SCIENCE (2019)
CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency
Navneet Matharu et al.
SCIENCE (2019)
Engineering of CRISPR-Cas12b for human genome editing
Jonathan Strecker et al.
NATURE COMMUNICATIONS (2019)
CRISPR-based Activation of Endogenous Neurotrophic Genes in Adipose Stem Cell Sheets to Stimulate Peripheral Nerve Regeneration
Mu-Nung Hsu et al.
THERANOSTICS (2019)
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs
Dinh-Duc Nguyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
LncRNA THOR promotes human renal cell carcinoma cell growth
Xue-ting Ye et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
CRISPR-Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta-Galactoside Alpha-2,6-Sialyltransferase 1 in CHO Cells
Nicolas Marx et al.
BIOTECHNOLOGY JOURNAL (2018)
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
Silvana Konermann et al.
CELL (2018)
Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene
X. Shawn Liu et al.
CELL (2018)
Delivering CRISPR: a review of the challenges and approaches
Christopher A. Lino et al.
DRUG DELIVERY (2018)
CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells
Jia Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Activation of the Anti-Aging and Cognition-Enhancing Gene Klotho by CRISPR-dCas9 Transcriptional Effector Complex
Ci-Di Chen et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation
Ana M. Moreno et al.
MOLECULAR THERAPY (2018)
Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
Seuk-Min Ryu et al.
NATURE BIOTECHNOLOGY (2018)
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
Luke W. Koblan et al.
NATURE BIOTECHNOLOGY (2018)
CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins
David Couvin et al.
NUCLEIC ACIDS RESEARCH (2018)
Generation of App knock-in mice reveals deletion mutations protective against Alzheimer's disease-like pathology
Kenichi Nagata et al.
NATURE COMMUNICATIONS (2018)
CRISPR-Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta-Galactoside Alpha-2,6-Sialyltransferase 1 in CHO Cells
Nicolas Marx et al.
BIOTECHNOLOGY JOURNAL (2018)
Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors
Hong Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer
Hoda Kardooni et al.
CANCERS (2018)
Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments
Michelle L. Kimberland et al.
JOURNAL OF BIOTECHNOLOGY (2018)
Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
Boris Kantor et al.
MOLECULAR THERAPY (2018)
Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9
Yanlin Wang et al.
MOLECULAR THERAPY (2018)
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Johnny H. Hu et al.
NATURE (2018)
High-fidelity CRISPR/Cas9-based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis
Xingbo Xu et al.
NATURE COMMUNICATIONS (2018)
Treatment of a metabolic liver disease by in vivo genome base editing in adult mice
Lukas Villiger et al.
NATURE MEDICINE (2018)
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes
Lucas B. Harrington et al.
SCIENCE (2018)
A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome
Worawan B. Limpitikul et al.
CIRCULATION RESEARCH (2017)
New CRISPR-Cas systems from uncultivated microbes
David Burstein et al.
NATURE (2017)
Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase
Peter Stepper et al.
NUCLEIC ACIDS RESEARCH (2017)
Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer
Shuai Zhen et al.
ONCOTARGET (2017)
CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease
Nivya Kolli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer
Wan-xin Peng et al.
MOLECULAR CANCER (2017)
A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells
Yingjie Yu et al.
MOLECULAR CANCER (2017)
Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
Rachid El Fatimy et al.
MOLECULAR THERAPY (2017)
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
Alex Mas Monteys et al.
MOLECULAR THERAPY (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions
Y. Bill Kim et al.
NATURE BIOTECHNOLOGY (2017)
Non-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Y. Chang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Sickle Cell Disease
Frederic B. Piel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
Leonela Amoasii et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells
Masahiro Okada et al.
EPIGENETICS & CHROMATIN (2017)
LncRNA AK023948 is a positive regulator of AKT
Pratirodh Koirala et al.
NATURE COMMUNICATIONS (2017)
miR-29b contributes to multiple types of muscle atrophy
Jin Li et al.
NATURE COMMUNICATIONS (2017)
Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery
Holly A. Rees et al.
NATURE COMMUNICATIONS (2017)
CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo
Xin Xu et al.
ONCOTARGET (2017)
Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus
Joo Youn Park et al.
SCIENTIFIC REPORTS (2017)
Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
Wenying Huo et al.
JOURNAL OF CANCER (2017)
Increased Expression of Laminin Subunit Alpha 1 Chain by dCas9-VP160
Arnaud Perrin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T: A base editors with higher efficiency and product purity
Alexis C. Komor et al.
SCIENCE ADVANCES (2017)
Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA
David J. Sanz et al.
PLOS ONE (2017)
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation
Hsin-Kai Liao et al.
CELL (2017)
Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders
Dania Wojtal et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing
Angelo Amabile et al.
CELL (2016)
CRISPR-on system for the activation of the endogenous human INS gene
C. A. Gimenez et al.
GENE THERAPY (2016)
CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy
Charis L. Himeda et al.
MOLECULAR THERAPY (2016)
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
Christoph Seeger et al.
MOLECULAR THERAPY (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions
Sumiyo Morita et al.
NATURE BIOTECHNOLOGY (2016)
Angelman syndrome - insights into a rare neurogenetic disorder
Karin Buiting et al.
NATURE REVIEWS NEUROLOGY (2016)
Repurposing the CRISPR-Cas9 system for targeted DNA methylation
Aleksandar Vojta et al.
NUCLEIC ACIDS RESEARCH (2016)
Lateral Thinking: How Histone Modifications Regulate Gene Expression
Moyra Lawrence et al.
TRENDS IN GENETICS (2016)
Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis
R. Singh et al.
CELL DEATH & DISEASE (2016)
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter
Samrat Roy Choudhury et al.
ONCOTARGET (2016)
Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype
Sidinh Luc et al.
CELL REPORTS (2016)
A CRISPR-based approach for targeted DNA demethylation
Xingxing Xu et al.
CELL DISCOVERY (2016)
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kaminski et al.
SCIENTIFIC REPORTS (2016)
Precision Modulation of Neurodegenerative Disease-Related Gene Expression in Human iPSC-Derived Neurons
Sabrina Mahalia Heman-Ackah et al.
SCIENTIFIC REPORTS (2016)
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
Chunsheng Dong et al.
ANTIVIRAL RESEARCH (2015)
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche et al.
CELL (2015)
Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus
S. Zhen et al.
GENE THERAPY (2015)
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Catherine L. Bladen et al.
HUMAN MUTATION (2015)
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Sergey Shmakov et al.
MOLECULAR CELL (2015)
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Silvana Konermann et al.
NATURE (2015)
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
Isaac B. Hilton et al.
NATURE BIOTECHNOLOGY (2015)
Highly efficient Cas9-mediated transcriptional programming
Alejandro Chavez et al.
NATURE METHODS (2015)
Cas9-mediated targeting of viral RNA in eukaryotic cells
Aryn A. Price et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
Weijun Zhu et al.
RETROVIROLOGY (2015)
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
David G. Ousterout et al.
NATURE COMMUNICATIONS (2015)
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
Vyas Ramanan et al.
SCIENTIFIC REPORTS (2015)
Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs
Peng Xu et al.
SCIENTIFIC REPORTS (2015)
CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells
Weixia Jing et al.
BIOMED RESEARCH INTERNATIONAL (2015)
CRISPR/Cas9-mediated genome editing of Epstein Barr virus in human cells
Kit-San Yuen et al.
JOURNAL OF GENERAL VIROLOGY (2015)
In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9
Shuai Zhen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
Rajat M. Gupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Robert J. Citorik et al.
NATURE BIOTECHNOLOGY (2014)
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
David Bikard et al.
NATURE BIOTECHNOLOGY (2014)
RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection
Jianbin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
Wenhui Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
Zheng Hu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Targeting Hepatitis B Virus With CRISPR/Cas9
Christoph Seeger et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Epigenetic Characterization of the FMR1 Promoter in Induced Pluripotent Stem Cells from Human Fibroblasts Carrying an Unmethylated Full Mutation
Celine E. F. de Esch et al.
STEM CELL REPORTS (2014)
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi et al.
CELL (2013)
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Luke A. Gilbert et al.
CELL (2013)
CRISPR RNA-guided activation of endogenous human genes
Morgan L. Maeder et al.
NATURE METHODS (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Thomas Gaj et al.
TRENDS IN BIOTECHNOLOGY (2013)
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Hirotaka Ebina et al.
SCIENTIFIC REPORTS (2013)
FOXAI mutations in hormone-dependent cancers
Jessica L. L. Robinson et al.
FRONTIERS IN ONCOLOGY (2013)
Bcl11a is essential for lymphoid development and negatively regulates p53
Yong Yu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Beta-thalassemia
Renzo Galanello et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
CRISPR provides acquired resistance against viruses in prokaryotes
Rodolphe Barrangou et al.
SCIENCE (2007)
An SCN9A channelopathy causes congenital inability to experience pain
James J. Cox et al.
NATURE (2006)
The evolution of adaptive immune systems
MD Cooper et al.
CELL (2006)
A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes
DH Haft et al.
PLOS COMPUTATIONAL BIOLOGY (2005)
Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin
A Bolotin et al.
MICROBIOLOGY-SGM (2005)
Identification of genes that are associated with DNA repeats in prokaryotes
R Jansen et al.
MOLECULAR MICROBIOLOGY (2002)
Biological significance of a family of regularly spaced repeats in the genomes of Archaea, bacteria and mitochondria
FJM Mojica et al.
MOLECULAR MICROBIOLOGY (2000)
Share Paper
